¥512.00 ($3.25)

+3.00 (+0.59%)

Weekly Expected Move ±1.9%

¥490 ¥499 ¥509 ¥519 ¥528

JPX · Healthcare · Medical - Specialties · Tech Score Buy · Power 51 · ¥54.2B mcap · 29M float · 0.848% daily turnover

Revenue

$14.4B -22.9% ▼

4Y CAGR: -4.7%

Gross Profit

$8.2B -33.3% ▼

4Y CAGR: -12.9%

Operating Income

$4.2B -49.2% ▼

4Y CAGR: -21.7%

Net Income

$5.5B -13.0% ▼

4Y CAGR: +5.2%

EPS (Diluted)

$51.08 -13.3% ▼

4Y CAGR: +3.3%

EBITDA

$5.3B -41.0% ▼

4Y CAGR: -11.2%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$17.5B	$15.7B	$18.4B	$18.6B	$14.4B
YoY Growth	+0.0%	-10.2%	+17.6%	+1.0%	-22.9%
Cost of Revenue	$3.2B	$6.9B	$5.9B	$6.3B	$6.1B
Gross Profit	$14.3B	$8.8B	$12.5B	$12.3B	$8.2B
Gross Margin	81.8%	56.1%	67.8%	66.2%	57.2%
R&D Expenses	$776M	$723M	$0	$1.1B	$0
SG&A Expenses	$2.3B	$3.8B	$3.0B	$4.1B	$4.0B
Operating Expenses	$3.1B	$3.8B	$4.5B	$4.1B	$4.0B
Operating Income	$11.2B	$5.0B	$8.0B	$8.3B	$4.2B
Operating Margin	64.1%	31.7%	43.6%	44.4%	29.2%
Interest Expense	$8M	$22M	$31M	$103M	$264M
Income Before Tax	$8.0B	$4.7B	$7.8B	$8.2B	$7.9B
Tax Expense	$3.5B	$1.6B	$2.1B	$1.9B	$2.4B
Net Income	$4.5B	$3.0B	$5.8B	$6.3B	$5.5B
Net Margin	25.7%	19.4%	31.3%	33.9%	38.2%
EPS (Diluted)	$44.81	$30.35	$57.74	$58.90	$51.08
EBITDA	$8.6B	$5.3B	$8.6B	$9.0B	$5.3B
Shares Outstanding	100M	100M	100M	107M	108M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$6.4B	$5.6B	$5.6B	$1.0B	$2.4B	$5.9B	$2.4B	$3.7B
Cost of Revenue	$1.6B	$1.7B	$1.7B	$930M	$738M	$1.9B	$976M	$1.9B
Gross Profit	$4.8B	$3.9B	$4.0B	$90M	$1.6B	$4.0B	$1.4B	$1.8B
Gross Margin	74.9%	70.3%	70.5%	8.8%	68.8%	67.7%	59.1%	48.0%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.1B	$1.1B	$1.2B	$1.2B	$1.1B	$1.3B	$1.2B	$1.1B
Operating Expenses	$1.1B	$1.1B	$1.2B	$1.2B	$1.1B	$1.3B	$1.2B	$1.1B
Operating Income	$3.7B	$2.8B	$2.8B	-$1.1B	$548M	$2.7B	$258M	$690M
Operating Margin	58.3%	50.2%	49.6%	-104.5%	23.1%	45.8%	10.8%	18.6%
Interest Expense	$16M	$18M	$31M	$38M	$51M	$61M	$73M	$80M
Income Before Tax	$3.8B	$2.8B	$2.8B	-$1.1B	$506M	$2.4B	$601M	$4.4B
Tax Expense	$1.1B	$781M	$813M	-$766M	$148M	$697M	$218M	$1.3B
Net Income	$2.7B	$2.0B	$2.0B	-$330M	$358M	$1.7B	$383M	$3.1B
Net Margin	42.0%	35.8%	34.8%	-32.4%	15.1%	28.8%	16.0%	82.3%
EPS (Diluted)	$25.20	$18.55	$17.94	$-3.05	$3.33	$15.85	$3.55	$28.35
EBITDA	$3.9B	$3.0B	$3.0B	-$876M	$739M	$2.9B	$596M	$1.1B
Shares Outstanding	107M	107M	109M	108M	107M	107M	108M	108M

197A.T JPX